Colin is a Director and a key leader in our UK / Swiss Life Science practice. He has been with Deloitte since 2011 working in the US firm until 2014 when he moved to the UK.
Colin’s client advisory work in the Life Sciences sector ranges across strategy and operations focused on the R&D function including operating model development and implementation as well as post-merger integration (PMI). These engagements have been serving client Boards and their senior leadership teams in R&D, Commercial and Supply Chain
Colin is an author of our annual R&D productivity analysis study which reviews productivity of the worlds largest pharmaceutical businesses.
Recent engagements include leadership of the R&D integration workstream for a Med Tech merger leading the European team as well as global responsibility for the R&D and Manufacturing footprints; and design of a new Pharma vaccine R&D model post integration
Colin has a B.Sc (Hons). in Microbiology from the University of London, Queen Mary & Westfield and a Marketing Diploma from the Chartered Institute of Marketing.
Anna leads Deloitte’s Integration & Separation Advisory (I&SA) team in Switzerland and the EMEA Centre of Excellence for Life Sciences I&SA. Anna is recognized as one of the foremost integration advisors in EMEA and has supported over 30 integrations and separations including many landmark deals. She provides advice and challenge to senior management and boards in planning and delivering complex cross-border integrations and operational carve outs.
Responsive Web Design powered by 